AnaptysBio Stock: The Royalty Waterfall Is About To Reverse (NASDAQ:ANAB)

seekingalpha.com · 2026-07-29

AnaptysBio (ANAB) stock shifts to a lean royalty company tied to GSK’s Jemperli. Jemperli royalties escalate with sales. Read here for a detailed analysis.

Read the full story at seekingalpha.com →